Total Payments
$23,642
2024 Payments
$4,459
Companies
36
Transactions
265
Medicare Patients
6,136
Medicare Billing
$1.4M
Payment Breakdown by Category
Consulting$11,665 (49.3%)
Food & Beverage$6,715 (28.4%)
Other$3,880 (16.4%)
Travel$1,292 (5.5%)
Education$89.99 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,665 | 2 | 49.3% |
| Food and Beverage | $6,715 | 255 | 28.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,880 | 3 | 16.4% |
| Travel and Lodging | $1,292 | 4 | 5.5% |
| Education | $89.99 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,369 | 55 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $4,157 | 8 | $0 (2024) |
| PFIZER INC. | $581.89 | 24 | $0 (2023) |
| LEO Pharma Inc. | $501.71 | 21 | $0 (2024) |
| GENZYME CORPORATION | $496.50 | 13 | $0 (2022) |
| ABBVIE INC. | $434.03 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $282.43 | 10 | $0 (2023) |
| Almirall LLC | $235.37 | 8 | $0 (2023) |
| Incyte Corporation | $224.21 | 7 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $220.35 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,459 | 21 | SUN PHARMACEUTICAL INDUSTRIES INC. ($4,091) |
| 2023 | $7,930 | 33 | Novartis Pharmaceuticals Corporation ($7,435) |
| 2022 | $7,188 | 41 | Novartis Pharmaceuticals Corporation ($6,321) |
| 2021 | $1,233 | 44 | GENZYME CORPORATION ($211.85) |
| 2020 | $704.00 | 31 | Novartis Pharmaceuticals Corporation ($127.25) |
| 2019 | $942.32 | 51 | PFIZER INC. ($220.18) |
| 2018 | $907.32 | 33 | PFIZER INC. ($276.31) |
| 2017 | $278.98 | 11 | Allergan Inc. ($76.64) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $25.53 | General |
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: DERMATOLOGY | ||||||
| 08/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: DERMATOLOGY | ||||||
| 07/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: DERMATOLOGY | ||||||
| 06/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 05/31/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Dermatology | ||||||
| 05/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.58 | General |
| Category: Dermatology | ||||||
| 05/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $60.86 | General |
| 04/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: Immunology | ||||||
| 04/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $149.96 | General |
| 02/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $10.36 | General |
| Category: DERMATOLOGY | ||||||
| 01/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Inflammation | ||||||
| 11/06/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Dermatology | ||||||
| 10/25/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2023 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,756 | 2,682 | $804,078 | $482,748 |
| 2022 | 24 | 1,760 | 3,021 | $636,069 | $403,145 |
| 2021 | 24 | 1,720 | 2,736 | $578,280 | $376,609 |
| 2020 | 16 | 900 | 1,343 | $289,943 | $184,558 |
Total Patients
6,136
Total Services
9,782
Medicare Billing
$1.4M
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 241 | 312 | $262,960 | $165,278 | 62.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 132 | 181 | $89,043 | $66,304 | 74.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 78 | 114 | $87,138 | $60,155 | 69.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 132 | 179 | $68,674 | $34,846 | 50.7% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 130 | 143 | $80,954 | $32,297 | 39.9% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 24 | 24 | $21,388 | $16,111 | 75.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 193 | $20,270 | $13,477 | 66.5% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 30 | 36 | $17,075 | $12,854 | 75.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 114 | $16,872 | $10,979 | 65.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 80 | 95 | $12,730 | $8,897 | 69.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 102 | 127 | $15,875 | $8,890 | 56.0% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 11 | 11 | $9,690 | $7,368 | 76.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 111 | 151 | $14,792 | $6,386 | 43.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 35 | 40 | $14,000 | $4,985 | 35.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 87 | 103 | $7,014 | $4,905 | 69.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 20 | 22 | $8,140 | $4,016 | 49.3% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $10,116 | $3,899 | 38.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 17 | $8,758 | $3,835 | 43.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 84 | 527 | $5,270 | $3,096 | 58.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 57 | 87 | $5,655 | $2,670 | 47.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 35 | 50 | $3,350 | $2,244 | 67.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $6,200 | $2,196 | 35.4% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 12 | 12 | $5,640 | $2,089 | 37.0% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 18 | $4,243 | $1,592 | 37.5% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $3,587 | $1,315 | 36.7% |
About Dr. Michael Mortazie, DO
Dr. Michael Mortazie, DO is a MOHS-Micrographic Surgery healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1457616914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mortazie, DO has received a total of $23,642 in payments from pharmaceutical and medical device companies, with $4,459 received in 2024. These payments were reported across 265 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($11,665).
As a Medicare-enrolled provider, Mortazie has provided services to 6,136 Medicare beneficiaries, totaling 9,782 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Orange, CA
- Active Since 07/11/2012
- Last Updated 09/17/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457616914
Products in Payments
- COSENTYX (Biological) $6,892
- Odomzo (Drug) $3,880
- COSENTYX (Drug) $671.56
- EUCRISA (Drug) $581.89
- DUPIXENT (Biological) $417.68
- TREMFYA (Drug) $299.90
- ENSTILAR (Drug) $272.04
- Otezla (Drug) $230.73
- ADBRY (Biological) $193.42
- RINVOQ (Biological) $185.85
- SKYRIZI (Biological) $167.03
- TALTZ (Drug) $147.49
- OPZELURA (Drug) $134.22
- Seysara (Drug) $130.40
- Sotyktu (Drug) $117.05
- BOTOX COSMETIC (Biological) $95.51
- DUOBRII (Drug) $94.21
- AMELUZ (Drug) $93.27
- VTAMA (Drug) $89.29
- LIBTAYO (Biological) $87.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.